Skip to main content

Table 1 Baseline characteristics of ICU patients with Candida BSI

From: Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study

 

Inappropriate (n = 80)

Appropriate (n = 10)

P value*

Age

57.2 ± 16.5

55.1 ± 21.8

0.774

Gender (Female)

38 (47.5%)

6 (60.0%)

0.518

Race (African American)

22 (27.5%)

4 (40.0%)

0.466

Medical service

50 (62.5%)

10 (100%)

0.027

CBSI on admission

18 (22.5%)

10 (100%)

<0.001

Comorbidities

   

   CHF

18 (22.5%)

3 (30.0%)

0.693

   CAD

19 (23.8%)

4 (40.0%)

0.270

   DM

25 (31.3%)

4 (40.0%)

0.721

   COPD

16 (20.0%)

1 (10.0%)

0.680

   Liver disease

4 (5.0%)

0

1.000

   ESRD

7 (8.8%)

2 (20.0%)

0.261

   HIV

1 (1.3%)

0

1.000

   Cancer

23 (28.8%)

2 (20.0%)

0.720

   Organ transplant

1 (1.3%)

1 (10.0%)

0.218

APACHE II score

16.3 ± 6.7

16.3 ± 7.8

0.990

MV

52 (65.0%)

6 (60.0%)

0.739

Pressors

23 (28.8%)

4 (40.0%)

0.479

CVC present

70 (87.5%)

8 (80.0%)

0.617

  1. *P values derived using Student's t-test for continuous and Fisher's exact test for categorical variables